MarkAClementsMDPhD, CPI

Pediatric Endocrinology • Kansas City, MO

Assistant Professor, Pediatrics, University of Missouri, Kansas City School of Medicine

Join to view full profile

Dr. Clements is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clements' full profile

Already have an account?

Office
2401 Gillham Rd
Kansas City, MO 64108
Phone+1 816-234-3000

Education & Training

Children’s Mercy HospitalFellowship, Pediatric Endocrinology, 2006 - 2008
Children’s Mercy HospitalResidency, Pediatrics, 2003 - 2006
Washington University in St. Louis School of MedicineClass of 2003

Certifications & Licensure

KS State Medical License 2006 - 2025
MO State Medical License 2006 - 2025
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes Start of enrollment: 2016 Dec 29
Completed
Phase 3
HCT Cash-Only INcentive to Promote Mealtime Insulin DOSE Engagement Start of enrollment: 2022 Feb 14
Recruiting
Not Applicable
A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes Start of enrollment: 2022 Mar 24
Completed
Phase 1
Home Video-based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children Start of enrollment: 2019 Oct 15
Active, not recruiting
Not Applicable
Roles: Contact
Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart) Start of enrollment: 2024 Jan 16
Recruiting
Roles: Principal Investigator, Contact
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D) Start of enrollment: 2024 May 27
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
Melanie R Shapiro, Erin M Tallon, Matthew E Brown, Amanda L Posgai, Mark A Clements
Diabetologia. 2024-12-19
Predicting Hypoglycemia and Hyperglycemia Risk During and After Activity for Adolescents with Type 1 Diabetes.
Simon Bergford, Michael C Riddell, Robin L Gal, Susana R Patton, Mark A Clements
Diabetes Technology & Therapeutics. 2024-10-01
Early Results of an Innovative Scalable Digital Treatment for Diabetes Distress in Families of School-Age Children with Type 1 Diabetes.
Susana R Patton, Jessica S Pierce, Nicole Kahhan, Matthew Benson, Mark A Clements
Children. 2024-09-26

Journal Articles

Dyslipidemia and Statin Use in Youth and Adults Ages 10‐<40 Years in the T1D Exchange Clinic Registry
Michael R Rickels, Mark A Clements, Diabetes, Obesity and Metabolism

Authored Content

ENDO 2021 Preview: Harnessing Data to Help with DiabetesMarch 2021

Press Mentions

At-Home Digital Health Innovations Transforming Diabetes CareApril 4th, 2022
AI Reveals Link Between Family History and Type 1 Diabetes RisksMarch 28th, 2022
Power of Artificial Intelligence in Type 1 Diabetic PatientsMarch 23rd, 2022
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow